Supplements
Neuropsychiatric disease
Vol. 455, No. 7215 pp 889–923
In this supplement
Neuropsychiatric diseases, such as schizophrenia, depression and autism, are a huge burden on society, impairing the health of those affected, as well as their ability to learn and to work. After half a century of concerted effort, researchers are now making progress towards defining the biological basis of these diseases. Technological advances in the areas of genomics and large-scale studies, as well as the development of new animal models, are improving our understanding of these diseases and are offering the prospect of fundamentally different options for treatment.
Editorial
Neuropsychiatric disease
I-han Chou & Tanguy Chouard
doi:10.1038/455889a
Top of page
Introduction
A glimmer of light for neuropsychiatric disorders
Steven E. Hyman
doi:10.1038/nature07454
Abstract | Full Text | PDF (140KB)
Top of page
Reviews
The molecular neurobiology of depression
Vaishnav Krishnan & Eric J. Nestler
doi:10.1038/nature07455
Abstract | Full Text | PDF (1,240KB)
Neuroligins and neurexins link synaptic function to cognitive disease
Thomas C. Südhof
doi:10.1038/nature07456
Abstract | Full Text | PDF (977KB)
Failure of neuronal homeostasis results in common neuropsychiatric phenotypes
Melissa B. Ramocki & Huda Y. Zoghbi
doi:10.1038/nature07457
Abstract | Full Text | PDF (660KB)
Copy-number variations associated with neuropsychiatric conditions
Edwin H. Cook Jr & Stephen W. Scherer
doi:10.1038/nature07458
Abstract | Full Text | PDF (168KB)